Lan Shao

3.3k total citations · 1 hit paper
57 papers, 2.0k citations indexed

About

Lan Shao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lan Shao has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lan Shao's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (14 papers) and Blood Pressure and Hypertension Studies (8 papers). Lan Shao is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (14 papers) and Blood Pressure and Hypertension Studies (8 papers). Lan Shao collaborates with scholars based in China and United States. Lan Shao's co-authors include Zuo Chen, Zengwu Wang, Linfeng Zhang, Congyi Zheng, Ye Tian, Manlu Zhu, Runlin Gao, Ying Dong, Guang Hao and Jiali Wang and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Lan Shao

56 papers receiving 2.0k citations

Hit Papers

Status of Hypertension in China 2018 2026 2020 2023 2018 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Shao China 18 805 336 286 280 272 57 2.0k
Kyuwoong Kim South Korea 26 396 0.5× 402 1.2× 158 0.6× 216 0.8× 305 1.1× 88 2.2k
Young Hoon Lee South Korea 26 508 0.6× 272 0.8× 247 0.9× 122 0.4× 339 1.2× 174 2.4k
Yan Borné Sweden 28 412 0.5× 480 1.4× 249 0.9× 368 1.3× 375 1.4× 121 2.6k
Amy Earley United States 20 648 0.8× 288 0.9× 261 0.9× 81 0.3× 238 0.9× 41 2.3k
Rehan Qayyum United States 23 467 0.6× 403 1.2× 122 0.4× 129 0.5× 198 0.7× 105 2.1k
Linfeng Zhang China 21 1.1k 1.4× 350 1.0× 248 0.9× 82 0.3× 488 1.8× 82 2.6k
Yao Lu China 31 873 1.1× 191 0.6× 279 1.0× 167 0.6× 499 1.8× 139 3.0k
Xiangfeng Lu China 29 808 1.0× 362 1.1× 146 0.5× 118 0.4× 332 1.2× 146 3.3k
Li Fan China 22 635 0.8× 147 0.4× 275 1.0× 86 0.3× 222 0.8× 120 2.0k

Countries citing papers authored by Lan Shao

Since Specialization
Citations

This map shows the geographic impact of Lan Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shao more than expected).

Fields of papers citing papers by Lan Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shao. The network helps show where Lan Shao may publish in the future.

Co-authorship network of co-authors of Lan Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Shao. A scholar is included among the top collaborators of Lan Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Shao. Lan Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Xin, Congyi Zheng, Zhen Hu, et al.. (2024). Effects of loneliness and isolation on cardiovascular diseases: a two sample Mendelian Randomization Study. Journal of Geriatric Cardiology. 21(3). 340–348. 4 indexed citations
3.
Wang, Xin, Congyi Zheng, Linfeng Zhang, et al.. (2023). Workplace-based primary prevention intervention reduces incidence of hypertension: a post hoc analysis of cluster randomized controlled study. BMC Medicine. 21(1). 214–214. 2 indexed citations
4.
Gu, Xiaodong, Yibing Xu, Lan Shao, et al.. (2023). Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis. Open Medicine. 18(1). 20230653–20230653. 5 indexed citations
6.
Wang, Wenxian, Lan Shao, Yibing Xu, et al.. (2022). Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study. BMC Pulmonary Medicine. 22(1). 179–179. 11 indexed citations
7.
Wang, Wenxian, Xiaodong Gu, Liping Wang, et al.. (2021). The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study. Cancer Immunology Immunotherapy. 71(7). 1693–1703. 35 indexed citations
8.
Xu, Yibing, Yiping Zhang, Zhengbo Song, Wenxian Wang, & Lan Shao. (2021). Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer. Cancer Management and Research. Volume 13. 6309–6317. 6 indexed citations
9.
Zhang, Linfeng, Zengwu Wang, Xin Wang, et al.. (2020). Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012–2015. Obesity Research & Clinical Practice. 14(2). 119–126. 84 indexed citations
10.
Shao, Lan, et al.. (2019). The efficacy and safety of anlotinib treatment for advanced lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Shao, Lan, Wenxian Wang, Zhengbo Song, & Yiping Zhang. (2019). <p>The efficacy and safety of anlotinib treatment for advanced lung cancer</p>. OncoTargets and Therapy. Volume 12. 6549–6554. 26 indexed citations
12.
Wang, Zengwu, Xin Wang, Guang Hao, et al.. (2018). A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012–2015. International Journal of Cardiology. 275. 165–170. 32 indexed citations
13.
Dong, Ying, Xin Wang, Linfeng Zhang, et al.. (2018). High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study. Journal of Epidemiology & Community Health. 73(2). 188–192. 39 indexed citations
15.
Wang, Zengwu, Zuo Chen, Xin Wang, et al.. (2018). The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey. The American Journal of Cardiology. 122(5). 793–798. 83 indexed citations
16.
Zhang, Linfeng, Zengwu Wang, Yundai Chen, et al.. (2018). Prevalence and risk factors associated with chronic kidney disease in adults living in 3 different altitude regions in the Tibetan Plateau. Clinica Chimica Acta. 481. 212–217. 13 indexed citations
17.
Fan, Guohui, Zengwu Wang, Linfeng Zhang, et al.. (2015). [Prevalence, awareness, treatment and control of hypertension in rural areas in North China in 2013].. PubMed. 95(8). 616–20. 6 indexed citations
18.
Shao, Lan, Beibei Zhang, Baochai Lin, et al.. (2014). Efficacy and safety of icotinib in Chinese patients with advanced nonsmall cell lung cancer after failure of chemotherapy. Chinese Medical Journal. 127(2). 266–271. 14 indexed citations
19.
Lin, Baochai, et al.. (2013). Preoperative elevation of serum C‐reactive protein as an indicator of poor prognosis for early‐stage esophageal squamous cell carcinoma. The Kaohsiung Journal of Medical Sciences. 29(12). 662–666. 18 indexed citations
20.
Song, Zhengbo, Baochai Lin, Lan Shao, & Yiping Zhang. (2013). Brain Metastases from Esophageal Cancer: Clinical Review of 26 Cases. World Neurosurgery. 81(1). 131–135. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026